Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-22-PRCRP-CDA: DoD Peer Reviewed, Career Development Award

Closed Closed August 2, 2022 Opportunity W81XWH-22-PRCRP-CDA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2022.

• Total funding$9.6 million
• Expected awards15
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

· The PRCRP is seeking to advance cancer research through development of early-career investigators. Dependent on the accomplishments of candidates, the PRCRP will offer two distinct early-career development options: the Fellow Option (CDA-FO) and the Virtual Cancer Center Scholar Option (CDA-SO). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. This award supports impactful research projects with an emphasis on discovery. ○ Fellow Option: The PI must be an early-career researcher or physician-scientist (referred to as a Fellow) within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). Principal Investigators suitable for the Fellow Option include investigators who may not be on a tenure track and may only have laboratory space but not a completely separate laboratory from a more established investigator. The intention of the Fellow Option is to support the early-career investigators toward wider independence and success. ○ Virtual Cancer Center Scholar Option: Supports an independent, highly accomplished early-career investigator (referred to as a Scholar) to conduct impactful research under the guidance of an experienced cancer researcher (i.e., Career Guide). Scholars will commit to participate in the FY20 PRCRP Virtual Cancer Center (VCC) (CSVCC – Convergent Science Virtual Cancer Center). The unique, interactive VCC focuses on fostering the next generation of cancer researchers. This award provides intensive mentoring, national networking, and a peer group for junior faculty. Scholars are required to interact with the VCC Director, Deputy Director, and fellow Scholars in addition to their Career Guide. The intention of the Scholar Option is to support the highly accomplished investigator toward the goal of leadership in cancer. It is the responsibility of the PI to select the option that best aligns with their current career stage. The option should be selected based on the eligibility defined in the program announcement, and not on the amount of the budget. It is incumbent upon the early-career investigator to select the suitable option.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.